Sam Rebello

1.5k total citations
58 papers, 1.1k citations indexed

About

Sam Rebello is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Physiology. According to data from OpenAlex, Sam Rebello has authored 58 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cardiology and Cardiovascular Medicine, 13 papers in Hematology and 11 papers in Physiology. Recurrent topics in Sam Rebello's work include Nitric Oxide and Endothelin Effects (11 papers), Neuroscience of respiration and sleep (8 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Sam Rebello is often cited by papers focused on Nitric Oxide and Endothelin Effects (11 papers), Neuroscience of respiration and sleep (8 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Sam Rebello collaborates with scholars based in United States, Switzerland and India. Sam Rebello's co-authors include Anil Gulati, Benedict R. Lucchesi, Robert J. Leadley, Alison W. Gagnon, Liguo Chi, Ashok Kumar, Sam Hariry, Venkateswar Jarugula, Sujoy Roy and Govind Singh and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Sam Rebello

58 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sam Rebello United States	21	357	256	215	156	146	58	1.1k
Wolfram Steinke Germany	15	487 1.4×	582 2.3×	591 2.7×	103 0.7×	45 0.3×	31	1.7k
Dongdan Zheng China	21	293 0.8×	169 0.7×	402 1.9×	52 0.3×	45 0.3×	30	1.2k
Justin Chapman United States	13	169 0.5×	716 2.8×	628 2.9×	85 0.5×	198 1.4×	19	1.8k
Laine J. Murphey United States	24	494 1.4×	149 0.6×	325 1.5×	28 0.2×	222 1.5×	38	1.8k
PP Nawroth Germany	15	116 0.3×	344 1.3×	279 1.3×	72 0.5×	71 0.5×	44	1.3k
Magdalena Łomnicka Poland	16	190 0.5×	213 0.8×	395 1.8×	83 0.5×	29 0.2×	30	972
Jeremiah Stitham United States	22	211 0.6×	152 0.6×	501 2.3×	66 0.4×	94 0.6×	33	1.2k
Suwan Wang United States	24	295 0.8×	247 1.0×	722 3.4×	58 0.4×	33 0.2×	43	2.1k
A.J. Lusis United States	15	166 0.5×	202 0.8×	791 3.7×	126 0.8×	60 0.4×	28	1.9k
Yoshisuke Haruna Japan	17	266 0.7×	350 1.4×	441 2.1×	46 0.3×	34 0.2×	23	1.6k

Countries citing papers authored by Sam Rebello

Since Specialization

Citations

This map shows the geographic impact of Sam Rebello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Rebello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Rebello more than expected).

Fields of papers citing papers by Sam Rebello

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sam Rebello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Rebello. The network helps show where Sam Rebello may publish in the future.

Co-authorship network of co-authors of Sam Rebello

This figure shows the co-authorship network connecting the top 25 collaborators of Sam Rebello. A scholar is included among the top collaborators of Sam Rebello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sam Rebello. Sam Rebello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sonpavde, Guru, Justin Call, Gerald S. Falchook, et al.. (2024). A first-in-human (FIH), phase 1/2, dose-escalation, dose-optimization, and dose-expansion study of PARP1-selective inhibitor IMP1734 in participants with advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). TPS3191–TPS3191. 2 indexed citations

Gu, Helen, Catherine Dutreix, Sam Rebello, et al.. (2017). Simultaneous Physiologically Based Pharmacokinetic (PBPK) Modeling of Parent and Active Metabolites to Investigate Complex CYP3A4 Drug-Drug Interaction Potential: A Case Example of Midostaurin. Drug Metabolism and Disposition. 46(2). 109–121. 25 indexed citations

Pal, Parasar, Tsu‐Han Lin, Tapan Majumdar, et al.. (2015). Effect of Renal Impairment on the Pharmacokinetics of Pradigastat, a Novel Diacylglycerol Acyltransferase1 (DGAT1) Inhibitor. Clinical Pharmacokinetics. 54(7). 751–760. 3 indexed citations

Ayalasomayajula, Surya, Phillip J. Koo, Tapan Majumdar, et al.. (2015). Assessment of pharmacokinetic drug-drug interaction between pradigastat and acetaminophen in healthy subjects. European Journal of Clinical Pharmacology. 71(4). 425–432. 5 indexed citations

Langenickel, Thomas, John G. Roberts, Parasar Pal, et al.. (2015). Pharmacokinetic drug–drug interaction assessment between LCZ696, an angiotensin receptor neprilysin inhibitor, and hydrochlorothiazide, amlodipine, or carvedilol. Clinical Pharmacology in Drug Development. 4(6). 407–417. 21 indexed citations

Hirano, Masaru, Parasar Pal, Tsu‐Han Lin, et al.. (2015). Effect of Hepatic Impairment on the Pharmacokinetics of Pradigastat, a Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor. Clinical Pharmacokinetics. 54(7). 761–770. 6 indexed citations

Ménard, Joël, Dean F. Rigel, Catherine E. Watson, et al.. (2014). Aldosterone synthase inhibition: cardiorenal protection in animal disease models and translation of hormonal effects to human subjects. Journal of Translational Medicine. 12(1). 340–340. 47 indexed citations

Rebello, Sam, Sally Zhao, Sam Hariry, et al.. (2011). Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects. European Journal of Clinical Pharmacology. 68(5). 697–708. 58 indexed citations

Liang, Guyan, Suzanne C. Aldous, Julian Levell, et al.. (2011). Structure-based library design and the discovery of a potent and selective mast cell β-tryptase inhibitor as an oral therapeutic agent. Bioorganic & Medicinal Chemistry Letters. 22(2). 1049–1054. 16 indexed citations

10.

Hopkins, Corey R., Steven S. Kaye, Henry W. Pauls, et al.. (2005). Design, synthesis, and biological activity of potent and selective inhibitors of mast cell tryptase. Bioorganic & Medicinal Chemistry Letters. 15(11). 2734–2737. 29 indexed citations

11.

Rebello, Sam, Charles Kasiewski, Ross Bentley, et al.. (2001). Superiority of Enoxaparin Over Heparin in Combination With a GPIIb/IIIa Receptor Antagonist During Coronary Thrombolysis in Dogs. Thrombosis Research. 102(3). 261–271. 13 indexed citations

12.

Rebello, Sam, Charles Kasiewski, Wei Wang, et al.. (2001). Role of Short-Term Inhibition of Factor Xa by FXV673 in Arterial Passivation: A Study in a Chronic Model of Thrombosis in Conscious Dogs. Journal of Cardiovascular Pharmacology. 38(2). 288–297. 9 indexed citations

13.

Rebello, Sam, et al.. (2000). Antithrombotic Efficacy of Single Subcutaneous Administration of a Recombinant Nematode Anticoagulant Peptide (rNAP5) in a Canine Model of Coronary Artery Thrombolysis. Thrombosis Research. 98(6). 531–540. 3 indexed citations

14.

Leadley, Robert J., Liguo Chi, Sam Rebello, & Alison W. Gagnon. (2000). Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents. Journal of Pharmacological and Toxicological Methods. 43(2). 101–116. 75 indexed citations

15.

Annich, Gail M., Deborah Damm, Jürgen Meinhardt, et al.. (1999). Recombinant Kunitz Protease Inhibitory Domain of the Amyloid β-Protein Precursor as an Anticoagulant in Venovenous Extracorporeal Circulation in Rabbits. Thrombosis and Haemostasis. 82(11). 1474–1481. 9 indexed citations

16.

Huang, Jinbao, Sam Rebello, Jessica D. Faul, & Benedict R. Lucchesi. (1999). Correlation between the in vivoEff icacy of GPIIb/IIIa Receptor Antagonists (m7E3, MK-383 and DMP-728) and ex vivo Platelet Inhibition. Pharmacology. 58(5). 252–264. 4 indexed citations

17.

Rebello, Sam, Sujoy Roy, Pramod R. Saxena, & Anil Gulati. (1995). Systemic hemodynamic and regional circulatory effects of centrally administered endothelin-1 are mediated through ETA receptors. Brain Research. 676(1). 141–150. 25 indexed citations

18.

Singh, Govind, et al.. (1995). Effect of diaspirin crosslinked and stroma-reduced hemoglobin on mean arterial pressure and endothelin-1 concentration in rats. Life Sciences. 56(17). 1433–1442. 42 indexed citations

19.

Sharma, Avadhesh C., et al.. (1994). Regional Circulatory and Systemic Hemodynamic Effects of Diaspirin Cross-Linked Hemoglobin in the Rat. Artificial Cells Blood Substitutes and Biotechnology. 22(3). 593–602. 24 indexed citations

20.

Gulati, Anil & Sam Rebello. (1992). Characteristics of endothelin receptors in the central nervous system of spontaneously hypertensive rats. Neuropharmacology. 31(3). 243–250. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact